Archos (FR:ALJXR) has released an update.
Archos has reported a remarkable 90% growth in turnover for H1 2024, reaching €16.5 million, bolstered by the successful integration of Elexo into its Logic Instrument group and the commercialization of its MedTech products. The company expects continued growth with the launch of a new range of consumer electronics and strategic expansion in both Defense and Industry mobile solutions and Home patient medical devices segments. Key financial details and the positive impacts of this growth on the company’s financial statements will be discussed further on August 7, 2024.
For further insights into FR:ALJXR stock, check out TipRanks’ Stock Analysis page.
